Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules targeting cancer and inflammatory diseases. Its structure supports derivatization for enhancing binding affinity and selectivity in drug design. Also employed in research settings to explore heterocyclic compound reactivity and to build more complex quinazoline-based scaffolds with potential therapeutic activity.